JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 166 filers reported holding JUNO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $754,000 | -33.0% | 40,017 | +6.6% | 0.00% | 0.0% |
| Q3 2016 | $1,126,000 | -19.2% | 37,533 | +3.6% | 0.00% | 0.0% |
| Q2 2016 | $1,393,000 | +143.5% | 36,226 | +141.1% | 0.00% | 0.0% |
| Q1 2016 | $572,000 | -7.9% | 15,027 | +6.4% | 0.00% | 0.0% |
| Q4 2015 | $621,000 | +44.8% | 14,119 | +33.9% | 0.00% | – |
| Q3 2015 | $429,000 | +128.2% | 10,546 | +198.8% | 0.00% | – |
| Q2 2015 | $188,000 | -12.1% | 3,530 | 0.0% | 0.00% | – |
| Q1 2015 | $214,000 | -96.8% | 3,530 | -97.3% | 0.00% | -100.0% |
| Q4 2014 | $6,710,000 | – | 128,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |